ClinicalTrials.Veeva

Menu

Endotracheal Cardiac Output Monitor (ECOM) for Patients Undergoing Liver Transplantation

Mayo Clinic logo

Mayo Clinic

Status

Terminated

Conditions

Liver Transplantation

Treatments

Device: ECOM ETT

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT01299441
10-007600

Details and patient eligibility

About

The purpose of this study is to determine whether the endotracheal cardiac output monitor (ECOM) is accurate and predictive in liver failure patients with hyperdynamic circulatory changes.

Enrollment

40 patients

Sex

All

Ages

18 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients undergoing liver transplantation surgery

Exclusion criteria

  • Patients who are anticipated to remain intubated postoperatively for greater than 24 hours.

Trial design

40 participants in 1 patient group

OLT patients intubated with ECOM ETT
Description:
Patients undergoing liver transplantation and intubated with ECOM endotracheal tube (ETT).
Treatment:
Device: ECOM ETT

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems